{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:06:56Z","timestamp":1786439216592,"version":"build-2736575974"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s13318-021-00696-y","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T14:13:18Z","timestamp":1625148798000},"page":"465-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Changes of Drug Pharmacokinetics in Patients with Short Bowel Syndrome: A Systematic Review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-7735","authenticated-orcid":false,"given":"Wallace Bok-Thoe","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Kiat","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-2632","authenticated-orcid":false,"given":"Lawrence Siu-Chun","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Eng-Hui","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-9236","authenticated-orcid":false,"given":"Elaine Ah-Gi","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"4","key":"696_CR1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0016-5085(03)70064-X","volume":"124","author":"AL Buchman","year":"2003","unstructured":"Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1111\u201334.","journal-title":"Gastroenterology"},{"issue":"1","key":"696_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cgh.2005.10.002","volume":"4","author":"SJ O'Keefe","year":"2006","unstructured":"O\u2019Keefe SJ, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006;4(1):6\u201310.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"696_CR3","doi-asserted-by":"publisher","first-page":"14S","DOI":"10.1177\/0148607113520005","volume":"38","author":"KA Tappenden","year":"2014","unstructured":"Tappenden KA. Pathophysiology of short bowel syndrome: considerations of resected and residual anatomy. J Parenter Enteral Nutr. 2014;38(1 Suppl):14S-22S.","journal-title":"J Parenter Enteral Nutr"},{"issue":"14","key":"696_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2165\/00003088-200443140-00001","volume":"43","author":"R Severijnen","year":"2004","unstructured":"Severijnen R, Bayat N, Bakker H, Tolboom J, Bongaerts G. Enteral drug absorption in patients with short small bowel\u202f: a review. Clin Pharmacokinet. 2004;43(14):951\u201362.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"696_CR5","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"696_CR6","unstructured":"RoB2 Development Group. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) 2019. https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2. Accessed 28 May 2021."},{"key":"696_CR7","unstructured":"RoB2 Development Group. The Risk Of Bias In Non-randomized Studies \u2013 of Interventions (ROBINS-I) assessment tool 2016. https:\/\/www.riskofbias.info\/welcome\/home\/current-version-of-robins-i\/robins-i-template-2016. Accessed 28 May 2021."},{"key":"696_CR8","unstructured":"The University of Adelaide. JBI\u2019s critical appraisal tools 2020. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 28 May 2021."},{"key":"696_CR9","unstructured":"University of Oxford. Oxford Centre for Evidence-Based Medicine: Levels of Evidence 2009. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed 28 May 2021."},{"issue":"2","key":"696_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0300-5089(21)00583-6","volume":"12","author":"E Weser","year":"1983","unstructured":"Weser E. Nutritional aspects of malabsorption: short gut adaptation. Clin Gastroenterol. 1983;12(2):443\u201361.","journal-title":"Clin Gastroenterol"},{"issue":"6","key":"696_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1521-6918(03)00082-9","volume":"17","author":"JA Vanderhoof","year":"2003","unstructured":"Vanderhoof JA, Young RJ. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. Best Pract Res Clin Gastroenterol. 2003;17(6):997\u20131015.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"696_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF02235648","volume":"15","author":"RR Levine","year":"1970","unstructured":"Levine RR. Factors affecting gastrointestinal absorption of drugs. Am J Dig Dis. 1970;15(2):171\u201388.","journal-title":"Am J Dig Dis"},{"issue":"1 Suppl","key":"696_CR13","doi-asserted-by":"publisher","first-page":"23S","DOI":"10.1177\/0148607114525210","volume":"38","author":"KA Tappenden","year":"2014","unstructured":"Tappenden KA. Intestinal adaptation following resection. J Parenter Enteral Nutr. 2014;38(1 Suppl):23S-31S.","journal-title":"J Parenter Enteral Nutr"},{"issue":"6","key":"696_CR14","first-page":"585","volume":"24","author":"JP Owens","year":"1990","unstructured":"Owens JP, Mirtallo JM, Murphy CC. Oral anticoagulation in patients with short-bowel syndrome. Drug Intell Clin Pharm. 1990;24(6):585\u20139.","journal-title":"Drug Intell Clin Pharm"},{"issue":"3","key":"696_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/j.1875-9114.1998.tb03129.x","volume":"18","author":"DF Brophy","year":"1998","unstructured":"Brophy DF, Ford SL, Crouch MA. Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy. 1998;18(3):646\u20139.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"696_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.thromres.2015.01.005","volume":"135","author":"LD Christensen","year":"2015","unstructured":"Christensen LD, Vinter-Jensen L, Rasmussen HH, Kristensen SR, Larsen TB. Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases. Thromb Res. 2015;135(3):568\u201370.","journal-title":"Thromb Res"},{"issue":"1","key":"696_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0148607186010001100","volume":"10","author":"PJ Kearns Jr","year":"1986","unstructured":"Kearns PJ Jr, O\u2019Reilly RA. Bioavailability of warfarin in a patient with severe short bowel syndrome. J Parenter Enteral Nutr. 1986;10(1):100\u20131.","journal-title":"J Parenter Enteral Nutr"},{"issue":"3","key":"696_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/0148607187011003316","volume":"11","author":"DM Lutomski","year":"1987","unstructured":"Lutomski DM, Palascak JE, Bower RH. Warfarin resistance associated with intravenous lipid administration. J Parenter Enteral Nutr. 1987;11(3):316\u20138.","journal-title":"J Parenter Enteral Nutr"},{"issue":"2","key":"696_CR19","first-page":"171","volume":"34","author":"JF Mitchell","year":"1977","unstructured":"Mitchell JF, Maas LC, Barger RC, Geizayd EA. Successful oral anticoagulant therapy in a patient with short bowel syndrome. Am J Hosp Pharm. 1977;34(2):171\u20132.","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"696_CR20","first-page":"99","volume":"80","author":"DM Lutomski","year":"1985","unstructured":"Lutomski DM, LaFrance RJ, Bower RH, Fischer JE. Warfarin absorption after massive small bowel resection. Am J Gastroenterol. 1985;80(2):99\u2013102.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"696_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0148607187011001102","volume":"11","author":"Z Gimmon","year":"1987","unstructured":"Gimmon Z. Oral anticoagulant therapy in patients who require nutritional support. J Parenter Enteral Nutr. 1987;11(1):102\u20133.","journal-title":"J Parenter Enteral Nutr"},{"issue":"1","key":"696_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/8755122518808291","volume":"35","author":"S Quintal","year":"2019","unstructured":"Quintal S, Culley CL, Hayashi A. Warfarin absorption in short bowel syndrome. J Pharm Technol. 2019;35(1):43\u20134.","journal-title":"J Pharm Technol"},{"issue":"5","key":"696_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/0091270005274550","volume":"45","author":"J Stangier","year":"2005","unstructured":"Stangier J, Eriksson BI, Dahl OE, Ahnfelt L, Nehmiz G, Stahle H, et al. Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. J Clin Pharmacol. 2005;45(5):555\u201363.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"696_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1538-7836.2007.02429.x","volume":"5","author":"GT Gerotziafas","year":"2007","unstructured":"Gerotziafas GT, Elalamy I, Depasse F, Perzborn E, Samama MM. In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban. J Thromb Haemost. 2007;5(4):886\u20138.","journal-title":"J Thromb Haemost"},{"key":"696_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.thromres.2017.10.025","volume":"160","author":"YW Cheung","year":"2017","unstructured":"Cheung YW, Barco S, Mathot RAA, van den Dool EJ, Stroobants AK, Serlie MJ, et al. Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: the PDER PAN study. Thromb Res. 2017;160:76\u201382.","journal-title":"Thromb Res"},{"issue":"2","key":"696_CR26","first-page":"419","volume":"112","author":"A Douros","year":"2014","unstructured":"Douros A, Schlemm L, Bolbrinker J, Ebinger M, Kreutz R. Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome. Thromb Haemost. 2014;112(2):419\u201320.","journal-title":"Thromb Haemost"},{"issue":"3","key":"696_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cjca.2017.12.021","volume":"34","author":"PT Pollak","year":"2018","unstructured":"Pollak PT, Sun GR, Kim RB. Personalized anticoagulation: guided apixaban dose adjustment to compensate for pharmacokinetic abnormalities related to short-bowel syndrome. Can J Cardiol. 2018;34(3):342.","journal-title":"Can J Cardiol"},{"key":"696_CR28","unstructured":"Pfizer Canada ULC, Bristol-Myers Squibb Canada Co. ELIQUIS (apixaban) product monograph 2019. https:\/\/www.pfizer.ca\/sites\/default\/files\/201910\/ELIQUIS_PM_229267_07Oct2019_Marketed_E.pdf. Accessed 28 May 2021."},{"issue":"1","key":"696_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/dmd.108.023143","volume":"37","author":"N Raghavan","year":"2009","unstructured":"Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, et al. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos. 2009;37(1):74\u201381.","journal-title":"Drug Metab Dispos"},{"issue":"7 Suppl","key":"696_CR30","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.cjca.2013.04.002","volume":"29","author":"IY Gong","year":"2013","unstructured":"Gong IY, Kim RB. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban. Can J Cardiol. 2013;29(7 Suppl):S24-33.","journal-title":"Can J Cardiol"},{"issue":"8","key":"696_CR31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cjca.2017.04.008","volume":"33","author":"M Gulilat","year":"2017","unstructured":"Gulilat M, Tang A, Gryn SE, Leong-Sit P, Skanes AC, Alfonsi JE, et al. Interpatient variation in rivaroxaban and apixaban plasma concentrations in routine care. Can J Cardiol. 2017;33(8):1036\u201343.","journal-title":"Can J Cardiol"},{"issue":"6","key":"696_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/1060028014526700","volume":"48","author":"E Faye","year":"2014","unstructured":"Faye E, Drouet L, De Raucourt E, Green A, Bal-Dit-Sollier C, Boudaoud L, et al. Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome. Ann Pharmacother. 2014;48(6):705\u201310.","journal-title":"Ann Pharmacother"},{"key":"696_CR33","doi-asserted-by":"crossref","unstructured":"Droppa M, Karathanos A, Gawaz M, Geisler T. Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting. BMJ Case Rep. 2015;\u00a02015:bcr2014205227.","DOI":"10.1136\/bcr-2014-205227"},{"key":"696_CR34","first-page":"248","volume":"17","author":"I Weliky","year":"1975","unstructured":"Weliky I, Neiss E. Absorption of procainamide from the human intestine. Clin Pharmacol Ther. 1975;17:248.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"696_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/0148607183007002154","volume":"7","author":"J Felser","year":"1983","unstructured":"Felser J, Hui KK. Procainamide absorption in short bowel syndrome. J Parenter Enteral Nutr. 1983;7(2):154\u20135.","journal-title":"J Parenter Enteral Nutr"},{"issue":"1","key":"696_CR36","first-page":"62","volume":"5","author":"SJ Vetticaden","year":"1986","unstructured":"Vetticaden SJ, Lehman ME, Barnhart GR, Barr WH. Digoxin absorption in a patient with short-bowel syndrome. Clin Pharm. 1986;5(1):62\u20134.","journal-title":"Clin Pharm"},{"issue":"2","key":"696_CR37","first-page":"220","volume":"71","author":"MM Krausz","year":"1979","unstructured":"Krausz MM, Berry E, Freund U, Levy M. Absorption of orally administered digoxin after massive resection of the small bowel. Am J Gastroenterol. 1979;71(2):220\u20133.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"696_CR38","first-page":"764","volume":"23","author":"WD Heizer","year":"1989","unstructured":"Heizer WD, Pittman AW, Hammond JE, Fitch DD, Bustrack JA, Hull JH. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes. Drug Intell Clin Pharm. 1989;23(10):764\u20139.","journal-title":"Drug Intell Clin Pharm"},{"issue":"5","key":"696_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/j.1552-4604.1985.tb02855.x","volume":"25","author":"DD Brown","year":"1985","unstructured":"Brown DD, Schmid J, Long RA, Hull JH. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules. J Clin Pharmacol. 1985;25(5):360\u20134.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"696_CR40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1177\/106002809402801104","volume":"28","author":"ED Ehrenpreis","year":"1994","unstructured":"Ehrenpreis ED, Guerriero S, Nogueras JJ, Carroll MA. Malabsorption of digoxin tablets, gel caps, and elixir in a patient with an end jejunostomy. Ann Pharmacother. 1994;28(11):1239\u201340.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"696_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0002-9343(80)90498-2","volume":"69","author":"CD Gerson","year":"1980","unstructured":"Gerson CD, Lowe EH, Lindenbaum J. Bioavailability of digoxin tablets in patients with gastrointestinal dysfunction. Am J Med. 1980;69(1):43\u20139.","journal-title":"Am J Med"},{"issue":"3","key":"696_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2125.1977.tb00726.x","volume":"4","author":"J Meier","year":"1977","unstructured":"Meier J, Nuesch E. Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect. Br J Clin Pharmacol. 1977;4(3):371\u20132.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"696_CR43","first-page":"398","volume":"7","author":"D Evard","year":"1983","unstructured":"Evard D, Le Quintrec Y, Aubry JP, Cheymol G, Cheymol A. Evaluation of pindolol absorption in malabsorption syndromes. Gastroenterol Clin Biol. 1983;7(4):398\u2013404.","journal-title":"Gastroenterol Clin Biol"},{"issue":"Suppl 2","key":"696_CR44","doi-asserted-by":"publisher","first-page":"97S","DOI":"10.1111\/j.1365-2125.1985.tb02749.x","volume":"19","author":"G Jobin","year":"1985","unstructured":"Jobin G, Cortot A, Godbillon J, Duval M, Schoeller JP, Hirtz J, et al. Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol. 1985;19(Suppl 2):97S-105S.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"696_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/00365521.2016.1230780","volume":"52","author":"ES Kolberg","year":"2017","unstructured":"Kolberg ES, Sue-Chu M, Rydning A. Heart rate control with oral metoprolol in a patient with Short Bowel Syndrome. Scand J Gastroenterol. 2017;52(1):92.","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 2","key":"696_CR46","doi-asserted-by":"publisher","first-page":"113S","DOI":"10.1111\/j.1365-2125.1985.tb02751.x","volume":"19","author":"J Godbillon","year":"1985","unstructured":"Godbillon J, Evard D, Vidon N, Duval M, Schoeller JP, Bernier JJ, et al. Investigation of drug absorption from the gastrointestinal tract of man.. III Metoprolol in the colon. Br J Clin Pharmacol. 1985;19(Suppl 2):113S-S118.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"696_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1476-5381.1973.tb08339.x","volume":"47","author":"RC Heading","year":"1973","unstructured":"Heading RC, Nimmo J, Prescott LF, Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol. 1973;47(2):415\u201321.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"696_CR48","first-page":"111","volume":"22","author":"EB Nelson","year":"1986","unstructured":"Nelson EB, Abernethy DR, Greenblatt DJ, Ameer B. Paracetamol absorption from a feeding jejunostomy. Br J Clin Pharmacol. 1986;22(1):111\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"696_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2125.1995.tb04457.x","volume":"39","author":"T Ueno","year":"1995","unstructured":"Ueno T, Tanaka A, Hamanaka Y, Suzuki T. Serum drug concentrations after oral administration of paracetamol to patients with surgical resection of the gastrointestinal tract. Br J Clin Pharmacol. 1995;39(3):330\u20132.","journal-title":"Br J Clin Pharmacol"},{"key":"696_CR50","doi-asserted-by":"crossref","unstructured":"Doddrell C, Tripathi SS. Successful use of pregabalin by the rectal route to treat chronic neuropathic pain in a patient with complete intestinal failure. BMJ Case Rep. 2015; 2015:bcr2015211511.","DOI":"10.1136\/bcr-2015-211511"},{"issue":"5","key":"696_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","volume":"36","author":"KC Lamp","year":"1999","unstructured":"Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet. 1999;36(5):353\u201373.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"696_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000237985","volume":"27","author":"T Bergan","year":"1981","unstructured":"Bergan T, Bjerke PE, Fausa O. Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers. Chemotherapy. 1981;27(4):233\u20138.","journal-title":"Chemotherapy"},{"issue":"6","key":"696_CR53","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1365-2125.2009.03534.x","volume":"68","author":"I Scholz","year":"2009","unstructured":"Scholz I, Oberwittler H, Riedel KD, Burhenne J, Weiss J, Haefeli WE, et al. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype. Br J Clin Pharmacol. 2009;68(6):906\u201315.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"696_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2004.08.077","volume":"139","author":"SM Breit","year":"2005","unstructured":"Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139(1):135\u201340.","journal-title":"Am J Ophthalmol"},{"issue":"20","key":"696_CR55","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.2169\/internalmedicine.55.6777","volume":"55","author":"M Ikuma","year":"2016","unstructured":"Ikuma M, Watanabe D, Yagura H, Ashida M, Takahashi M, Shibata M, et al. Therapeutic drug monitoring of anti-human immunodeficiency virus drugs in a patient with short bowel syndrome. Intern Med. 2016;55(20):3059\u201363.","journal-title":"Intern Med"},{"issue":"6","key":"696_CR56","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1445-5994.1998.tb01574.x","volume":"28","author":"S McDonald","year":"1998","unstructured":"McDonald S. Another case of high gentamicin clearance and volume of distribution in a patient with high output ileostomy. Aust N Z J Med. 1998;28(6):847\u20138.","journal-title":"Aust N Z J Med"},{"issue":"2","key":"696_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1445-5994.1997.tb00948.x","volume":"27","author":"TL Gaskin","year":"1997","unstructured":"Gaskin TL, Duffull SB. Enhanced gentamicin clearance associated with ileostomy fluid loss. Aust N Z J Med. 1997;27(2):196\u20137.","journal-title":"Aust N Z J Med"},{"issue":"5","key":"696_CR58","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jac\/33.5.1070","volume":"33","author":"LA Joe","year":"1994","unstructured":"Joe LA, Jacobs RA, Guglielmo BJ. Systemic absorption of oral fluconazole after gastrointestinal resection. J Antimicrob Chemother. 1994;33(5):1070.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"696_CR59","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.clinthera.2014.02.021","volume":"36","author":"D Tsunashima","year":"2014","unstructured":"Tsunashima D, Kawamura A, Murakami M, Sawamoto T, Undre N, Brown M, et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. Clin Ther. 2014;36(5):748\u201359.","journal-title":"Clin Ther"},{"issue":"4","key":"696_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/00003088-200140040-00004","volume":"40","author":"PE Wallemacq","year":"2001","unstructured":"Wallemacq PE, Verbeeck RK. Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Clin Pharmacokinet. 2001;40(4):283\u201395.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"696_CR61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/lt.500040502","volume":"4","author":"J Thielke","year":"1998","unstructured":"Thielke J, Martin J, Weber FL, Schroeder TJ, Goretsky S, Hanto DW. Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome. Liver Transpl Surg. 1998;4(5):432\u20134.","journal-title":"Liver Transpl Surg"},{"issue":"1","key":"696_CR62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1432-2277.2004.tb00382.x","volume":"17","author":"N Patel","year":"2004","unstructured":"Patel N, Smith S, Handa A, Darby C. The use of oral tacrolimus in a case of short bowel syndrome. Transpl Int. 2004;17(1):44\u20135.","journal-title":"Transpl Int"},{"issue":"3","key":"696_CR63","first-page":"200","volume":"87","author":"OM McCloskey","year":"2018","unstructured":"McCloskey OM, Woodman A, Mitchell A, Smyth J. The challenge of achieving adequate oral immunosuppression in a renal transplant recipient who develops short bowel syndrome (Sbs). Ulster Med J. 2018;87(3):200\u20131.","journal-title":"Ulster Med J"},{"issue":"2","key":"696_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1620\/tjem.221.113","volume":"221","author":"I Takeda","year":"2010","unstructured":"Takeda I, Kawagishi N, Sekiguchi S, Akamatsu Y, Sato K, Miyagi S, et al. Long-term outcome of living related renal transplantation in a patient with short bowel syndrome. Tohoku J Exp Med. 2010;221(2):113\u20138.","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"696_CR65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1432-2277.1999.tb00775.x","volume":"12","author":"M Novelli","year":"1999","unstructured":"Novelli M, Muiesan P, Mieli-Vergani G, Dhawan A, Rela M, Heaton ND. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. Transpl Int. 1999;12(6):463\u20135.","journal-title":"Transpl Int"},{"issue":"6","key":"696_CR66","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1399-3046.2006.00504.x","volume":"10","author":"DD Olio","year":"2006","unstructured":"Olio DD, Gupte G, Sharif K, Murphy MS, Lloyd C, McKiernan PJ, et al. Immunosuppression in infants with short bowel syndrome undergoing isolated liver transplantation. Pediatr Transplant. 2006;10(6):677\u201381.","journal-title":"Pediatr Transplant"},{"issue":"3","key":"696_CR67","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1034\/j.1399-3046.2001.00056.x","volume":"5","author":"T Hasegawa","year":"2001","unstructured":"Hasegawa T, Nara K, Kimura T, Soh H, Sasaki T, Azuma T, et al. Oral administration of tacrolimus in the presence of jejunostomy after liver transplantation. Pediatr Transplant. 2001;5(3):204\u20139.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"696_CR68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2125.1992.tb03998.x","volume":"33","author":"J Drewe","year":"1992","unstructured":"Drewe J, Beglinger C, Kissel T. The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol. 1992;33(1):39\u201343.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"696_CR69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00007691-200312000-00004","volume":"25","author":"RY Chenhsu","year":"2003","unstructured":"Chenhsu RY, Wu Y, Katz D, Rayhill S. Dose-adjusted cyclosporine c2 in a patient with jejunoileal bypass as compared to seven other liver transplant recipients. Ther Drug Monit. 2003;25(6):665\u201370.","journal-title":"Ther Drug Monit"},{"issue":"9","key":"696_CR70","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/gut.28.9.1166","volume":"28","author":"BF Allam","year":"1987","unstructured":"Allam BF, Tillman JE, Thomson TJ, Crossling FT, Gilbert LM. Effective intravenous cyclosporin therapy in a patient with severe Crohn\u2019s disease on parenteral nutrition. Gut. 1987;28(9):1166\u20139.","journal-title":"Gut"},{"issue":"7\u20138","key":"696_CR71","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/106002808802200710","volume":"22","author":"R Roberts","year":"1988","unstructured":"Roberts R, Sketris IS, Abraham I, Givner ML, MacDonald AS. Cyclosporine absorption in two patients with short-bowel syndrome. Drug Intell Clin Pharm. 1988;22(7\u20138):570\u20132.","journal-title":"Drug Intell Clin Pharm"},{"issue":"4","key":"696_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2125.1975.tb02777.x","volume":"2","author":"B Hulme","year":"1975","unstructured":"Hulme B, James VH, Rault R. Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol. 1975;2(4):317\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"696_CR73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3109\/00365528309181635","volume":"18","author":"H Bergrem","year":"1983","unstructured":"Bergrem H, Opedal I. Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding. Scand J Gastroenterol. 1983;18(4):545\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"696_CR74","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200544090-00001","volume":"44","author":"B Peng","year":"2005","unstructured":"Peng B, Lloyd P, Schran H. Clinical pharmacokinetics of imatinib. Clin Pharmacokinet. 2005;44(9):879\u201394.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"696_CR75","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1592\/phco.26.7.903","volume":"26","author":"JH Beumer","year":"2006","unstructured":"Beumer JH, Natale JJ, Lagattuta TF, Raptis A, Egorin MJ. Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndrome. Pharmacotherapy. 2006;26(7):903\u20137.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"696_CR76","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/10428190902777459","volume":"50","author":"R Yamazaki","year":"2009","unstructured":"Yamazaki R, Aisa Y, Mori T, Iketani O, Ikeda Y, Okamoto S. Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel. Leuk Lymphoma. 2009;50(4):670\u20132.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"696_CR77","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","volume":"111","author":"RA Larson","year":"2008","unstructured":"Larson RA, Druker BJ, Guilhot F, O\u2019Brien SG, Riviere GJ, Krahnke T, et al. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood. 2008;111(8):4022\u20138.","journal-title":"Blood"},{"issue":"4","key":"696_CR78","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/emj.18.4.236","volume":"18","author":"GW Kerr","year":"2001","unstructured":"Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236\u201341.","journal-title":"Emerg Med J"},{"issue":"8","key":"696_CR79","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1111\/j.1572-0241.1999.01323.x","volume":"94","author":"B Robbins","year":"1999","unstructured":"Robbins B, Reiss RA. Amitriptyline absorption in a patient with short bowel syndrome. Am J Gastroenterol. 1999;94(8):2302\u20134.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"696_CR80","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/0148607190014003326","volume":"14","author":"JE Broyles","year":"1990","unstructured":"Broyles JE, Brown RO, Self TH, Frederick RC, Luther RW. Nortriptyline absorption in short bowel syndrome. J Parenter Enteral Nutr. 1990;14(3):326\u20137.","journal-title":"J Parenter Enteral Nutr"},{"issue":"4","key":"696_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0033-3182(97)71455-5","volume":"38","author":"A DiMartini","year":"1997","unstructured":"DiMartini A. Short gut syndrome, tricyclic antidepressants, and prolonged QT interval syndromes. Psychosomatics. 1997;38(4):401\u20132.","journal-title":"Psychosomatics"},{"issue":"12","key":"696_CR82","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.clinthera.2014.09.018","volume":"36","author":"E Faye","year":"2014","unstructured":"Faye E, Corcos O, Lancelin F, Decleves X, Bergmann JF, Joly F, et al. Antidepressant agents in short bowel syndrome. Clin Ther. 2014;36(12):2029-2033 e3.","journal-title":"Clin Ther"},{"issue":"1","key":"696_CR83","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00544017","volume":"25","author":"U Gundert-Remy","year":"1983","unstructured":"Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E, Zurcher G, Da Prada M. Intestinal absorption of levodopa in man. Eur J Clin Pharmacol. 1983;25(1):69\u201372.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"696_CR84","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/thy.1995.5.249","volume":"5","author":"S Benvenga","year":"1995","unstructured":"Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5(4):249\u201353.","journal-title":"Thyroid"},{"issue":"1","key":"696_CR85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.17925\/EE.2013.09.01.40","volume":"9","author":"P Colucci","year":"2013","unstructured":"Colucci P, Yue CS, Ducharme M, Benvenga S. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol. 2013;9(1):40\u20137.","journal-title":"Eur Endocrinol"},{"issue":"1","key":"696_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jcem-59-1-139","volume":"59","author":"E Stone","year":"1984","unstructured":"Stone E, Leiter LA, Lambert JR, Silverberg JD, Jeejeebhoy KN, Burrow GN. L-thyroxine absorption in patients with short bowel. J Clin Endocrinol Metab. 1984;59(1):139\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"696_CR87","doi-asserted-by":"publisher","first-page":"941","DOI":"10.7326\/0003-4819-90-6-941","volume":"90","author":"F Azizi","year":"1979","unstructured":"Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med. 1979;90(6):941\u20132.","journal-title":"Ann Intern Med"},{"issue":"8","key":"696_CR88","first-page":"765","volume":"123","author":"DJ Topliss","year":"1980","unstructured":"Topliss DJ, Wright JA, Volpe R. Increased requirement for thyroid hormone after a jejunoileal bypass operation. Can Med Assoc J. 1980;123(8):765\u20136.","journal-title":"Can Med Assoc J"},{"issue":"3","key":"696_CR89","first-page":"245","volume":"10","author":"JS Bevan","year":"1986","unstructured":"Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10(3):245\u20136.","journal-title":"Int J Obes"},{"issue":"4","key":"696_CR90","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/milmed\/155.4.156","volume":"155","author":"RC Smallridge","year":"1990","unstructured":"Smallridge RC, Burman KD, Wartofsky L. Malabsorption of thyroxine, calcium, and vitamin D in a thyroparathyroidectomized woman: efficacy of therapy with medium-chain triglyceride oil. Mil Med. 1990;155(4):156\u20138.","journal-title":"Mil Med"},{"issue":"1\u20132","key":"696_CR91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.0954-6820.1980.tb09688.x","volume":"207","author":"A Aly","year":"1980","unstructured":"Aly A, Barany F, Kollberg B, Monsen U, Wisen O, Johansson C. Effect of an H2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn\u2019s disease. Acta Med Scand. 1980;207(1\u20132):119\u201322.","journal-title":"Acta Med Scand"},{"issue":"6","key":"696_CR92","first-page":"558","volume":"1","author":"J Russo Jr","year":"1982","unstructured":"Russo J Jr, Watson WA, Nelson EW, Schentag JJ. Cimetidine bioavailability after massive small bowel resection. Clin Pharm. 1982;1(6):558\u201361.","journal-title":"Clin Pharm"},{"issue":"1","key":"696_CR93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/00003088-197904010-00006","volume":"4","author":"L Backman","year":"1979","unstructured":"Backman L, Beerman B, Groschinsky-Grind M, Hallberg D. Malabsorption of hydrochlorothiazide following intestinal shunt surgery. Clin Pharmacokinet. 1979;4(1):63\u20138.","journal-title":"Clin Pharmacokinet"},{"issue":"5 Pt 1","key":"696_CR94","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/cpt1976195part1531","volume":"19","author":"B Beermann","year":"1976","unstructured":"Beermann B, Groschinsky-Grind M, Rosen A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther. 1976;19(5 Pt 1):531\u20137.","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-021-00696-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T14:35:21Z","timestamp":1699194921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-021-00696-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1007\/s13318-021-00696-y","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"9 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received to conduct this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Code Availability.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}